Jeffrey Ubben's Top 5 Q4 Stock Picks
ValueAct Capital, led by Jeffrey Ubben, recently submitted its latest 13F to the Securities and Exchange Commission for the reporting period of September 30.
Hedge Fund - ValueAct Capital
News, Interviews, and Investor Letters
- First
- << Previous
- 81 - 90
- Next >>
Highlights Among Hedge Funds' Latest Moves
At Insider Monkey we don't only analyze the quarterly 13F filings of over 730 smart money investors, but we also track their day-to-day moves disclosed via other filings with the SEC.
This Activist Investor's Picks May Be Lagging But They Are Poised For Long-Term Growth
Jeff Ubben of ValueAct Capital is one of the 40 or so billionaire investors that we follow at Insider Monkey.
Twenty-First Century Fox, Jeffrey Ubben Each Get What They Want In Deal
Jeffrey Ubben of ValueAct Capital has landed a board seat at the table of one of his biggest investments, Twenty-First Century Fox Inc (NASDAQ:FOX).
ValueAct Capital's Top Stock Picks Heading Into Q3
In its most recent 13F filing with the SEC for the reporting period quarter ending June 30, Jeffrey Ubben's ValueAct capital revealed an equity portfolio worth nearly $19 billion. Mr.
What's Next for Rolls-Royce Holding PLC (RR) after ValueAct Raises Stake to 5%?
Last week ended with some pretty interesting news from the UK, where activist investor ValueAct Capital disclosed a 5.44% stake in engine maker Rolls-Royce Holding PLC (LON:RR).
Activist Jeffrey Ubben Continues Reducing His Stake In Adobe Systems Incorporated (ADBE); Is The Upside Gone?
According to a recent Form 4 filing with the Securities and Exchange Commission, Jeffrey Ubben’s ValueAct Capital has unloaded 1.69 million shares of Adobe Systems Incorporated (NASDAQ:ADBE) through...
Insider ValueAct Capital Trims Stake In Adobe Systems Incorporated (ADBE), Has The Ceiling Been Hit?
According to a recent filing with the Securities and Exchange Commission, Jeffrey Ubben's ValueAct Capital has disposed of some 307,000 shares of Adobe Systems Incorporated (NASDAQ:ADBE) to drop its ...
When Jeffrey Ubben Likes A Stock Like Agrium Inc. (AGU), You Should Pay Attention
In a recent 13D filing with the Securities and Exchange Commission, Jeffrey Ubben’s ValueAct Capital disclosed a 6.8% ownership stake in Agrium Inc. (NYSE:AGU), amounting to 9.72 million shares.
Ubben Takes Big Profit From Valeant Pharmaceuticals International Inc. (VRX) Stake, Sells Over 4.3 Million Shares
Activist hedge fund firm ValueAct Capital, has filed a 13D with the SEC revealing its ownership stake in Valeant Pharmaceuticals International Inc.
- First
- << Previous
- 81 - 90
- Next >>